[go: up one dir, main page]

WO2007061162A1 - Ginseng à radicelles noires et son procédé de préparation - Google Patents

Ginseng à radicelles noires et son procédé de préparation Download PDF

Info

Publication number
WO2007061162A1
WO2007061162A1 PCT/KR2006/001407 KR2006001407W WO2007061162A1 WO 2007061162 A1 WO2007061162 A1 WO 2007061162A1 KR 2006001407 W KR2006001407 W KR 2006001407W WO 2007061162 A1 WO2007061162 A1 WO 2007061162A1
Authority
WO
WIPO (PCT)
Prior art keywords
ginseng
black
rootlet
red ginseng
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2006/001407
Other languages
English (en)
Inventor
Sung-Keun Choi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DAEDONG KOREA GINSENG Co Ltd
Original Assignee
DAEDONG KOREA GINSENG Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DAEDONG KOREA GINSENG Co Ltd filed Critical DAEDONG KOREA GINSENG Co Ltd
Publication of WO2007061162A1 publication Critical patent/WO2007061162A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481—Astragalus (milkvetch)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A61K36/076—Poria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/254—Acanthopanax or Eleutherococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/34—Campanulaceae (Bellflower family)
    • A61K36/344—Codonopsis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9068—Zingiber, e.g. garden ginger
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Definitions

  • the present invention relates to a black rootlet ginseng containing more saponin and process for preparing the same, which comprises the steps of (a) adding Astragalus membranaceus, Codonopis lanceolata, Acanthopanacis Cortex, Liriope platyphylla, Porta cocos, Zingiberis Rhizoma to a solvent; (b) concentrating the mixture by heating to obtain a concentrated solution; (c) saturating a red ginseng in the concentrated solution; (e) braising the saturated red ginseng; (f) desiccating the braised red ginseng; (g) repeating the step (e) to (f) to obtain a black rootlet ginseng.
  • the red ginseng is composed of amino acid, saponin, fatty acid such as stearic acid, palmitic acid, oleic acid, and panacene that is the volatile matter and the source of the special aroma of the red ginseng.
  • the condensed liquor of the red ginseng When the condensed liquor of the red ginseng is waved, the bubbles are generated continually. It is the vegetable components known as the saponin. Also it is known as the component related to the medicine effects of the red ginseng.
  • the saponin contents is little in the body of the ginseng which is made up of 60% by weight, but the root, outer periderm and cortex of the red ginseng is known as the storage of a great part of the saponin contents.
  • the saponin contents of small red ginseng have more saponin contents than that of big red ginseng.
  • the saponin contents in the part of the red ginseng are different, that the major root has 1.9 % and the side root has 2.94 %. More bitter red ginseng has more saponin and more efficacious.
  • Saponin of the 4-year red ginseng is 2.84 % and the 6-year is 2.19 %. Despite of 30 % of differences, the quality of the two is not apparent.
  • the ginseng and the red ginseng are good for enhancing the resistance, regulating the internal secretion, regulating the blood pressure, promoting the metabolism, diminishing inflammation, renewing from the enervation, regulating the neurasthenic, prolonging the life, strengthening the blood vessel, developing the immunity, strengthening the stomach, synthesizing the DNA, preventing the cancer, preventing the diabetes, enhancing the growth and so on.
  • the ginseng and the red ginseng are called catholicon that can cure all diseases.
  • the ginseng is classified by the producing area, root, size, shape, part and rank.
  • the ginseng is also differentiated by the effect as the medicine and the food. When it is used for the sake of prevention, it is a medicine.
  • the ginseng is hard to be preserved in water content of 80 to 85 %. So it is manufactured as the white ginseng and the red ginseng for the long-storage. In 1894, the red ginseng was protected by Korea Commerce Department as monopolization system.
  • the tea of the red ginseng is manufactured by extracting and concentrating the red ginseng. And it is classified as the extracting tea and the powder tea.
  • the representative of the red ginseng tea is the granular tea manufactured by desiccating the liquor that is composed the extracted red ginseng and the glucose. With the enhancement of the health consciousness, the extracted tea containing the glucose has gradually lost its market.
  • an object of the present invention is to solve the above-mentioned conventional technical problems and provide a black rootlet ginseng containing more saponin and process for preparing the same.
  • the present invention provides a process for preparing black rootlet ginseng, comprising the steps of: (a) adding Astragalus membranaceus, Codonopis lanceolata, Acanthopanacis Cortex, Liriope platyphylla, Poria cocos, Zingiberis Rhizoma to a solvent; (b) concentrating the mixture by heating to obtain a concentrated solution; (c) saturating a red ginseng in the concentrated solution; (e) braising the saturated red ginseng; (f) desiccating the braised red ginseng; (g) repeating the step (e) to (f) to obtain a black rootlet ginseng.
  • the process comprises the steps of (a) adding 15 to 25% by weight of Astragalus membranaceus, 15 to 25% by weight of Codonopis lanceolata, 15 to 25% by weight of Acanthopanacis Cortex, 15 to 20% by weight of Liriope platyphylla, 15 to 20% by weight of Poria cocos, 5 to 10% by weight of Zingiberis Rhizoma to at least one solvent selected from the group consisting of water, methanol, ethanol and isopropyl alcohol; (b) braising the mixture firstly at 50 to 70 ° C for 1 to 6 hours, then secondly at 120 to 150 ° C with high pressure for 1 to 6 hours; (c) concentrating the braised mixture by heating to obtain 1 to 10 brix of concentrated solution; (d) saturating a red ginseng in the concentrated solution for one night; (e) braising the saturated red ginseng at 50 to 70 °C for 1 to 6 hours; (f) desiccating the braised red
  • the present invention provides a black rootlet ginseng containing more saponin prepared by the above-mentioned process.
  • the primary technique of the present invention is to optimally process the black rootlet ginseng so that the saponin content is highest, thereby allowing that peoples can enjoy the ginseng tea containing more saponin by easily boiling the black rootlet ginseng in water.
  • the ginseng is classified as the major root in the central part and the rump root. Generally, the rump root has more saponin than that of the major root.
  • the central part of the ginseng is also classified according to the color such as the white ginseng, the red ginseng and the black rootlet ginseng. Because the ginseng manufactured by the process of the present invention is black, we name it the black rootlet ginseng.
  • the herbs used in saturating the red ginseng have many efficacies.
  • the efficacy of Astragalus membranaceus is to increase energy, build resistance to illness, increase production of white blood cells, fight bacteria, promote cell formation, stimulate appetite, fights fatigue, combat colds and lung problems, increase resistance to viral infections, aid in wound healing, reduce water retention in kidney complications, help to control blood sugar, reduce side effects of chemotherapy and other cancer treatments.
  • the effect of Codonopis lanceolata is to replenish yin of the lung and stomach, remove heat from the lung, promote fluid secretion, nourish yin and clear away lung-heat, nourish the stomach and promote the production of body fluid, clear the lungs and tonify yin, strengthen the stomach and promote the production of body fluids.
  • the efficacy o ⁇ Poria cocos is to promote urination, drain damp, strengthen spleen, quiet heart and calm spirit and help the amnesia, anxiety, restlessness, fatigue, tension, nervousness, dizziness, dysuria and urination problems, edema, insomnia, splenitis, stomach problems, diarrhea, tumors.
  • the efficacy of Zingiberis Rhizoma is to dispel cold, warm lung, stomach energy, stimulate yang-energy, anti-inflammatory, dissolves phlegm, control nausea and vomiting and motion sickness, promote blood circulation and prevent cancer.
  • the water and ethanol was mixed in the proportion of 1:1. Then, 20% by weight of Astragalus membranaceus, 20% by weight of Codonopis lanceolata, 20% by weight of Acanthopanacis Cortex, 17% by weight of Liriope platyphylla, 16% by weight of Poria cocos, 7% by weight of Zingiberis Rhizoma were added in the solvent mixture.
  • the mixture was braised firstly at 60 ° C for 3 hours, then secondly at 135 ° C for 3 hours.
  • the braised mixture was concentrated by heating to obtain 5 brix of concentrated solution. 100 g of the red ginseng was put in the concentrated solution and saturated for one night.
  • the saturated red ginseng was braised at 60 ° C for 3 hours in iron condenser.
  • the braised red ginseng was desiccated at 70 ° C in the loess desiccated room till the water content of the red ginseng was 28%.
  • the saturating, braising and desiccating steps were repeated 4 times to obtain a black rootlet ginseng.
  • the black rootlet ginseng was further braised at 135 ° C in high-pressure braiser for 3 hours.
  • the braised black rootlet ginseng was desiccated at 60 °C in the elvan desiccator for 3 hours till the water content of the black rootlet ginseng was 25%.
  • These braising and desiccating steps were repeated 4 times.
  • the black rootlet ginseng was further desiccated in the bulk desiccator till the final water content of the black rootlet ginseng is 14%. Finally, 90 g of the black rootlet ginseng was obtained.
  • the saponin content of the black rootlet ginseng prepared by the example was analyzed in the Ginseng Industry Institute of Chung-Ang University in Korea.
  • the experiment method was as follows:
  • the table 4 records the comparison of the saponin content in the black rootlet ginseng produced by the present invention and that in the red ginseng.
  • the components of black rootlet ginseng produced by the present invention are much higher than that of red ginseng.
  • the black rootlet ginseng is cooked in boiled water, most of all components above-mentioned are extracted. So, medical efficacies of the black rootlet ginseng are better than those of other products.
  • the medical efficacy of each components of black rootlet ginseng is as follows: Ginsenosides-Rg3 has the effect of curbing metastasis of cancer cell, curbing blood platelet coagulation, preventing people from thrombus. The experiment indicates that it also has the effect of protection of liver, relaxing blood vessel and reducing the resistant of cancer drug.
  • Ginsenosides-Rg2 has the effect of curbing blood platelet coagulation, anti-hemogtutination enzyme, retarding memory lose, curbing reproduction of smooth muscle cell, indus acetyl choline, curbing secrete of catecholamine and retarding the calcium entering inside of cell.
  • Ginsenosides-Rgl has good effect of enhancing immunity, curbing blood platelet coagulation, anti-hemogtutination, selective stimulatory function, enhancing memory, stimulating corticosteroid, promoting combination of protein, alleviating fatigue, exiting central nervous system, blood vessel dilatation, stemming harmful substance, improving sexual ability, resisting nephritis and increasing heart blood flow, increasing nervous cell exiting, enhancing cholesterol metabolism, resisting inflammation, promoting stem cell reproduction and DNA synthesis, protection of liver, and promoting hormone secrete.
  • Ginsenosides-Rf has the effect of alleviating pain, inhibiting lipid oxidation and curbing obstacle of brain growth.
  • Gindenosides-Re has the effect of renocortical stimulating hormone promoting secrete of hormone and adrenosterone secretion, promoting synthesis of DNA and RNA, protein of marrow cell, alleviating pain, curbing reproduction of smooth muscle cell, blood vessel dilatation, enhancing cholesterol metabolism and protection of liver.
  • Ginsenosides-Rd has the effect of renocortical stimulating hormone, adrenosterone and curbing reproduction of mesanchyme cell.
  • Ginenosides-Rc has the effect of alleviating pain, promoting secrete of adrenosterone, promoting produce of PGl 2, promoting synthesis of liver, blood serum cholesterol and RNA, promoting synthesis of marrow cell DNA and RNA, protein and adipose and curbing reproduction of mesenchyme cell.
  • Ginseneosides-Rb2 has the effect of promoting secretion of sugar and fat, resisting curbing decompose of fat bringing out by ACTHcAMP and epinephrine, maintaining metabolism balance of nitrogen, decreasing cholesterol and resisting arteriosclerosis, promoting secretion of DNA, RNA, renocortical stimulating hormone, adrenosterone, promoting synthesis of protein and fat, anti-cancer toxin hormone function, curbing reproduction of smooth muscle cell, curbing tumour blood vessel stlstod, improving appetite, promoting the oxidation, retarding active substance, stimulating liver APT supply, increasing content of APT and alleviating pain.
  • Ginsenosides-Rbl has the effect of curbing central nervous system and tranquillizing, central appetite repressing function, curbing offensive action, alleviating pain, resisting spasm, promoting secrete of renocortical stimulating hormone, adrenosterone secretary function tranquillizing, promoting synthesis of cholesterol, decreasing high cholesterol, neutral fat, free-fatty acid, promoting synthesis of DNA, RNA and protein of marrow cell and fat, promoting synthesis of protein and promoting exist of nervous cell, facilitate acetylcholine, improving memory, curbing coagulation of blood platelet, curbing inhibiting lipid oxidation, promoting blood vessel dilatation, promoting metabolism of cholesterol, resisting inflammation, protecting liver, induction of carbon tetrachloride, curbing liver protein phosphate, calcium accumulated inside of cell and stimulating appetite.
  • Ginsenosides-Rhl has the effect of curbing harmful substance to liver, promoting decomposition of tumour cell, inhibiting blood platelet coagulation and selective stimulatory effect.
  • Ginsenosides-Rh2 has the effect of curbing reproduction of cancer cell, inducing decomposition of cancer cell, curbing metastasis of carcinoma, curbing the reproduction of tumour and enhancing activity of anti-cancer drug.
  • the black rootlet ginseng containing more saponin can be produced by (a) adding Astragalus membranaceus, Codonopis lanceolata, Acanthopanacis Cortex, Liriope platyphylla, Poria cocos, Zingiberis Rhizoma to a solvent; (b) concentrating the mixture by heating to obtain a concentrated solution; (c) saturating a red ginseng in the concentrated solution; (e) braising the saturated red ginseng; (f) desiccating the braised red ginseng; (g) repeating the step (e) to (f).
  • the saponin content of the black rootlet ginseng according to the present invention is much higher than that of the red ginseng.

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

La présente invention concerne un ginseng à radicelles noires contenant davantage de saponine et son procédé de préparation. Le procédé consiste (a) à ajouter Astragalus membranaceus, Codonopis lanceolata, Acanthopanacis Cortex, Liriope platyphylla, Poria cocos, Zingiberis Rhizoma à un solvant, (b) à concentrer le mélange par chauffage en vue d'obtenir une solution concentrée, (c) à saturer un ginseng rouge dans la solution concentrée, (e) à braiser le ginseng rouge saturé, (f) à dessécher le ginseng rouge braisé, et (g) à répéter les étapes (e) à (f) en vue d'obtenir un ginseng à radicelles noires.
PCT/KR2006/001407 2005-11-24 2006-04-17 Ginseng à radicelles noires et son procédé de préparation Ceased WO2007061162A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2005-0112633 2005-11-24
KR1020050112633A KR101234605B1 (ko) 2005-11-24 2005-11-24 흑진삼 제조방법 및 그를 이용하여 제조된 흑진삼

Publications (1)

Publication Number Publication Date
WO2007061162A1 true WO2007061162A1 (fr) 2007-05-31

Family

ID=38067367

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2006/001407 Ceased WO2007061162A1 (fr) 2005-11-24 2006-04-17 Ginseng à radicelles noires et son procédé de préparation

Country Status (2)

Country Link
KR (1) KR101234605B1 (fr)
WO (1) WO2007061162A1 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2436388A4 (fr) * 2009-05-26 2012-11-28 Amorepacific Corp Composition pour accroître de la biodisponibilité de la saponine
CN103404675A (zh) * 2013-08-30 2013-11-27 黑龙江省新曙光刺五加生物科技开发有限公司 五加参预防流感茶及其制备方法
EP4226931A1 (fr) * 2022-02-11 2023-08-16 Daedong Korea Ginseng Co., Ltd Procédé de production d'un concentré de ginseng noir à teneur accrue en ginsénosides de prosapogénine en utilisant l'immersion dans l'extrait végétal, la technique de séchage continu à la vapeur et la concenration avec l'évaporateur à plaques suivie d'un traitement thermique.

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100864471B1 (ko) * 2007-04-25 2008-10-20 김재경 생약 추출액을 이용하여 제조되는 가공 인삼 및 그제조방법

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07278012A (ja) * 1994-04-11 1995-10-24 Sunstar Inc 新陳代謝促進剤およびそれを配合した食品
WO2000064278A1 (fr) * 1999-04-23 2000-11-02 E.Excel International, Inc. Produits de sante obtenus a partir du fruit du ginseng
KR20030012714A (ko) * 2001-08-04 2003-02-12 양상철 성장촉진용 건강식품의 제조방법
KR20030081930A (ko) * 2002-04-15 2003-10-22 이규환 홍삼을 주원료로 한 홍삼잼 제조방법 및 홍삼잼
KR20040063741A (ko) * 2003-01-08 2004-07-14 김종호 장뇌삼을 이용하여 장뇌홍삼 제조 및 그 제조 방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100496418B1 (ko) 2002-09-11 2005-06-28 한국파낙스제조(주) 흑미삼 제조방법 및 그를 이용하여 제조된 흑미삼
KR100543862B1 (ko) 2005-08-01 2006-01-23 (주) 흑삼코리아 활성성분의 함량이 뛰어난 흑삼 및 흑삼농축액
KR100600795B1 (ko) 2006-01-18 2006-07-19 (주) 흑삼코리아 진세노사이드 알지쓰리 성분의 함량이 뛰어난 흑삼 및 흑삼농축액
KR100864471B1 (ko) 2007-04-25 2008-10-20 김재경 생약 추출액을 이용하여 제조되는 가공 인삼 및 그제조방법

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07278012A (ja) * 1994-04-11 1995-10-24 Sunstar Inc 新陳代謝促進剤およびそれを配合した食品
WO2000064278A1 (fr) * 1999-04-23 2000-11-02 E.Excel International, Inc. Produits de sante obtenus a partir du fruit du ginseng
KR20030012714A (ko) * 2001-08-04 2003-02-12 양상철 성장촉진용 건강식품의 제조방법
KR20030081930A (ko) * 2002-04-15 2003-10-22 이규환 홍삼을 주원료로 한 홍삼잼 제조방법 및 홍삼잼
KR20040063741A (ko) * 2003-01-08 2004-07-14 김종호 장뇌삼을 이용하여 장뇌홍삼 제조 및 그 제조 방법

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2436388A4 (fr) * 2009-05-26 2012-11-28 Amorepacific Corp Composition pour accroître de la biodisponibilité de la saponine
US10172900B2 (en) 2009-05-26 2019-01-08 Amorepacific Corporation Composition with improved bioavailabilty of saponin and method for improving the bioavailability of saponin
CN103404675A (zh) * 2013-08-30 2013-11-27 黑龙江省新曙光刺五加生物科技开发有限公司 五加参预防流感茶及其制备方法
EP4226931A1 (fr) * 2022-02-11 2023-08-16 Daedong Korea Ginseng Co., Ltd Procédé de production d'un concentré de ginseng noir à teneur accrue en ginsénosides de prosapogénine en utilisant l'immersion dans l'extrait végétal, la technique de séchage continu à la vapeur et la concenration avec l'évaporateur à plaques suivie d'un traitement thermique.
CN116617703A (zh) * 2022-02-11 2023-08-22 大东高丽蔘 株式会社 利用连续蒸晒及复合浓缩技术的增加原皂苷元人参皂苷含量的黑参浓缩液的制备方法
US12004548B2 (en) 2022-02-11 2024-06-11 Daedong Korea Ginseng Co., Ltd Method for producing black ginseng concentrate with increased prosapogenin ginsenoside content using continuous steaming-drying technique and combined concentration technology
CN116617703B (zh) * 2022-02-11 2025-10-31 大东高丽蔘株式会社 利用连续蒸晒及复合浓缩技术的增加原皂苷元人参皂苷含量的黑参浓缩液的制备方法

Also Published As

Publication number Publication date
KR20070054764A (ko) 2007-05-30
KR101234605B1 (ko) 2013-02-22
KR101234605B9 (ko) 2021-11-19

Similar Documents

Publication Publication Date Title
CN104041799A (zh) 一种竹笋辣椒酱及其制备方法
CN104256025A (zh) 一种增强免疫、缓解疲劳的中药咖啡及其制备方法
CN103725572B (zh) 一种高丽红参酒的制备方法
CN111264735A (zh) 一种扶正固本提高免疫力防控疫毒的功能饮料
CN103952278A (zh) 玛咖矿泉酒及其制作方法
CN107996927A (zh) 提高免疫力的组合物、饮料及其制备方法
CN106987512A (zh) 一种保健酒及其制备方法
CN103416561A (zh) 一种苦菜茶及其发酵剂
CN111494555A (zh) 一种药食两用提高人体免疫功能的中药组合物及其制备方法
CN106234588A (zh) 一种健脾生姜解酒酸奶及其制备方法
WO2007061162A1 (fr) Ginseng à radicelles noires et son procédé de préparation
KR20210143037A (ko) 생약재 미네랄 효모 발효액을 이용하여 제조되는 발효 흑삼 조성물 및 그 제조방법
CN111358922A (zh) 温补肾阳改善寒性体质的中药组合物及其制备方法和应用
KR20120066380A (ko) 사슴뼈의 분말을 이용한 한방 건강보조식품
CN103719863B (zh) 一种高丽红参咀嚼片的制备方法
CN107307143A (zh) 一种养生茶及其制备方法
CN111418803A (zh) 一种养生汤的配制方法
CN105582412A (zh) 一种促进肿瘤压迫手术后愈合的复方制剂及其制备方法
CN105558101A (zh) 一种桂花香菜籽油的制备方法
CN105454750A (zh) 一种芝麻蜂蜜糖浆的制备方法
CN110584037A (zh) 一种食品人参膏及其制备方法
CN103750425A (zh) 一种高丽红参罗汉果汤的制备方法
CN108452047A (zh) 延缓衰老抑制肿瘤细胞生长改善心脑血管微循环的组合物
KR20040078076A (ko) 발포(發砲)에 의한 바이오한약탕제 침출(浸出)탕
CN107998353A (zh) 一种健脾、益气的中药制剂及其制备方法

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06732862

Country of ref document: EP

Kind code of ref document: A1